Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-06-066012
Filing Date
2006-12-19
Accepted
2006-12-19 19:04:24
Documents
1
Period of Report
2006-12-15

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION bos25963_bos1.html 4  
1 MAIN DOCUMENT DESCRIPTION bos25963_bos1.xml 4 2897
  Complete submission text file 0001209191-06-066012.txt   4700
Mailing Address 18701 120TH AVENUE NE SUITE 100 BOTHELL WA 98011
Business Address 18701 120TH AVENUE NE SUITE 100 BOTHELL WA 98011 4256083008
NORTHWEST BIOTHERAPEUTICS INC (Issuer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 22322 20TH AVENUE SE STE 150 BOTHELL WA 98021
Business Address
BOYNTON ALTON L (Reporting) CIK: 0001253935 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-33393 | Film No.: 061287809